MiR-195 inhibits migration, invasion and epithelial-mesenchymal transition (EMT) of endometrial carcinoma cells by targeting SOX4
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-195 inhibits migration, invasion and epithelial-mesenchymal transition (EMT) of endometrial carcinoma cells by targeting SOX4
Authors
Keywords
-
Journal
JOURNAL OF BIOSCIENCES
Volume 44, Issue 6, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-05
DOI
10.1007/s12038-019-9966-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long non-coding RNA PVT1 promotes malignancy in human endometrial carcinoma cells through negative regulation of miR-195-5p
- (2018) Fanfei Kong et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- LncRNA PVT1 epigenetically silences miR-195 and modulates EMT and chemoresistance in cervical cancer cells
- (2017) Ching-Ju Shen et al. JOURNAL OF DRUG TARGETING
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MicroRNA-340 Inhibits Tumor Cell Proliferation and Induces Apoptosis in Endometrial Carcinoma Cell Line RL 95-2
- (2016) Wei Xie et al. MEDICAL SCIENCE MONITOR
- MicroRNA-93 Promotes Epithelial–Mesenchymal Transition of Endometrial Carcinoma Cells
- (2016) Shuo Chen et al. PLoS One
- An overview of microRNAs
- (2015) Scott M. Hammond ADVANCED DRUG DELIVERY REVIEWS
- Global cancer statistics, 2012
- (2015) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- miR-195 Inhibits Tumor Progression by Targeting RPS6KB1 in Human Prostate Cancer
- (2015) C. Cai et al. CLINICAL CANCER RESEARCH
- MicroRNA-424 may function as a tumor suppressor in endometrial carcinoma cells by targeting E2F7
- (2015) QUAN LI et al. ONCOLOGY REPORTS
- Identification of subgroup-specific miRNA patterns by epigenetic profiling of sporadic and Lynch syndrome-associated colorectal and endometrial carcinoma
- (2015) Sippy Kaur et al. Clinical Epigenetics
- Identification of endometrioid endometrial carcinoma-associated microRNAs in tissue and plasma
- (2014) Ozora Tsukamoto et al. GYNECOLOGIC ONCOLOGY
- Sox4 Is a Key Oncogenic Target in C/EBPα Mutant Acute Myeloid Leukemia
- (2013) Hong Zhang et al. CANCER CELL
- Sox4 Is a Master Regulator of Epithelial-Mesenchymal Transition by Controlling Ezh2 Expression and Epigenetic Reprogramming
- (2013) Neha Tiwari et al. CANCER CELL
- Sox proteins: regulators of cell fate specification and differentiation
- (2013) Y. Kamachi et al. DEVELOPMENT
- MicroRNA-138 suppresses ovarian cancer cell invasion and metastasis by targeting SOX4 and HIF-1α
- (2013) Yu-Ming Yeh et al. INTERNATIONAL JOURNAL OF CANCER
- MicroRNA biogenesis: regulating the regulators
- (2012) Emily F. Finnegan et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Sox4 functions as a positive regulator of β-catenin signaling through upregulation of TCF4 during morular differentiation of endometrial carcinomas
- (2012) Makoto Saegusa et al. LABORATORY INVESTIGATION
- MiR-125b promotes proliferation and migration of type II endometrial carcinoma cells through targeting TP53INP1 tumor suppressor in vitro and in vivo
- (2011) Feizhou Jiang et al. BMC CANCER
- Prognostic Significance of Sox4 Expression in Human Cutaneous Melanoma and Its Role in Cell Migration and Invasion
- (2010) Seyed Mehdi Jafarnejad et al. AMERICAN JOURNAL OF PATHOLOGY
- Epigenetic Repression of microRNA-129-2 Leads to Overexpression of SOX4 Oncogene in Endometrial Cancer
- (2009) Y.-W. Huang et al. CANCER RESEARCH
- Changes in microRNA expression levels correlate with clinicopathological features and prognoses in endometrial serous adenocarcinomas
- (2009) Eri Hiroki et al. CANCER SCIENCE
- Interleukin-11 and Leukemia Inhibitory Factor Regulate the Adhesion of Endometrial Epithelial Cells: Implications in Fertility Regulation
- (2009) M. Marwood et al. ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started